Ivan Oransky

The tale of the secret publishing ban

We have an update on a post we published late last month.

We reported on March 31 that Tissue Engineering had retracted a paper by Xing Wei, of the, National Engineering Research Center of Genetic Medicine at Jinan University, in Guangzhou, China, because of image manipulation. The retraction notice for that paper, “Use of Decellularized Scaffolds Combined with Hyaluronic Acid and Basic Fibroblast Growth Factor for Skin Tissue Engineering, referred to another paper in the journal that was being retracted, but had not yet been. It also referred to a paper in a different journal that showed signs of misconduct, but that had yet to be retracted, either.

We were checking this week to see if the other papers had been retracted, mostly just to make sure our database was up to date. The second paper, Promoting the Recovery of Injured Liver with Poly (3-Hydroxybutyrate-Co-3-Hydroxyvalerate-Co-3-Hydroxyhexanoate) Scaffolds Loaded with Umbilical Cord-Derived Mesenchymal Stem Cells, has indeed been retracted, although the one in Tissue Engineering Constructs and Cell Substrates has not.

What was far more interesting, however, was that when we looked at a retraction notice for the first paper, we saw something we hadn’t seen in it before: Wei had earned an “indefinite ban” from publishing in the journal:

Journals have retracted or flagged more than 40 papers from China that appear to have used organ transplants from executed prisoners

Journals have retracted 30 papers, and added expressions of concern to 13 more, because the research likely involved organs from executed prisoners in China.

The issue surfaced as early as 2016, and two of the retractions occurred in 2017, but all of the other retractions, and all of the expressions of concern, happened after a February 2019 paper by Wendy Rogers of Macquarie University, in Sydney, Australia, and colleagues calling for the retraction of more than 400 papers

Weekend reads: Should expertise in COVID-19 modeling justify a reprieve for grant fraud?; bypassing publishing; “a torrent of ‘bad science?'”

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

Sending thoughts to our readers and wishing them the best in this uncertain time.

The week at Retraction Watch featured:

An “expression of concern” — or something very much like it — for a highly influential paper about hydroxychloroquine and COVID-19.
The eighth retraction for a researcher who sued his university for discrimination.
The 15th retraction for an author who engaged in fake peer review.
Some authors unhappy after their retraction count grows to five.

Here’s what was happening elsewhere:

Agriculture researcher up to 15 retractions for fake peer review

Christos Damalas, an agriculture researcher at Democritus University of Thrace, has had more papers retracted from Elsevier journals for fake peer review reports, giving him a total of 15.

The three most recent retractions appear, as did some previously, in Science of the Total Environment. Damalas also had papers retracted from Chemosphere and Land Use Policy in October. We reported on nine of his retractions last October. (For background on how fake peer review works, read this.)

Here’s a typical notice (the repeated “request of” appears in the three from Science of the Total Environment):

Weekend reads: COVID-19 and peer review; blaming a spell-checker for plagiarism; the fastest retracting country

Sending thoughts to our readers and wishing them the best in this uncertain time.

The week at Retraction Watch featured:

A retraction by a formerly high-profile researcher for “inadvertently misidentified” images;
the tale of the zombie papers;
recognition for a sleuth.

Here’s what was happening elsewhere:

Former UCSD prof who resigned amid investigation into China ties retracts paper for ‘inadvertently misidentified’ images

Kang Zhang, a formerly high-profile geneticist at the University of California, San Diego, who resigned his post last July amidst an investigation into undisclosed ties to China, has retracted a paper because some of its images were taken from other researchers’ work.

The paper, “Impaired lipid metabolism by age-dependent DNA methylation alterations accelerates aging,” was submitted to the Proceedings of the National Academy of Sciences (PNAS) last fall, months after Zhang’s resignation. One of Zhang’s fellow corresponding authors, Jian-Kang Zhu, used the journal’s “Contributed Submissions” process, in which “An NAS member may contribute up to two of her or his own manuscripts for publication in PNAS each year.”

PNAS published the paper on February 6 of this year. But on February 18, authors of a different paper, in Aging Cell, sent the editors of PNAS a letter, writing:

Weekend reads: Why coronavirus papers need a warning label; scientists correct the record

Sending thoughts to our readers and wishing them the best in this uncertain time.

The week at Retraction Watch featured:

A researcher who felt “shocked” and “physically ill” — but still corrected the record.
A retraction mystery in which none of the authors of a paper knew anything about it.
The retraction of a paper in Nature after years of scrutiny.

Here’s what was happening elsewhere:

A mystery: “none of the authors listed had any involvement with or knowledge of the article”

Even after close to 10 years of writing about retractions every day, some days we read retraction notices that make us say, “huh?”

Today is one of those days.

Take this retraction notice for “High-resolution ultrasound images in gouty arthritis to evaluate relationship between tophi and bone erosion,” a paper first published in Future Generation Computer Systems last year:

U Maryland group up to three retractions following investigation

A researcher at the University of Maryland, along with two former colleagues, has had three papers retracted in the past six months following an institutional investigation that found evidence of image manipulation.

The three retractions share three authors: Hua Zhou, Ying Hua Yang and John Basile, an associate professor of oncology and diagnostic sciences at the institution. The original papers appeared in Angiogenesis and PLOS ONE between 2011 and 2013.

Basile told Retraction Watch that he was prohibited from discussing the matter, based on statements from the university’s investigation committee, but that he did not think other papers from his lab co-authored with Zhou would be retracted.

One of the articles, “Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression,” has been cited 46 times, according to Clarivate Analytics’ Web of Science. Here’s the retraction notice from Angiogenesis, which was published earlier this month:

Nature paper on cancer retracted after years of scrutiny

Following five years of criticism, a group of researchers based at Stanford and elsewhere have retracted a 2006 paper in Nature for “image anomalies.”

The notice for “Lysyl oxidase is essential for hypoxia-induced metastasis” reads:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: